Mild ischemic injury leads to long-term alterations in the kidney: Amelioration by spironolactone administration

International Journal of Biological Sciences

Volumn 11, Issue 8, 2015, Pages 892-900

  Barrera Chimal, Jonatan ^a,b,d   Pérez Villalva, Rosalba ^a,b   Ortega, Juan Antonio ^a,b   Sánchez, Andrea ^a,b   Rodríguez Romo, Roxana ^a,b   Durand, Marta ^c   Jaisser, Frederic ^d   Bobadilla, Norma A ^a,b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b Nephrology Department of Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán   (Mexico)

^c Reproductive Biology Department of Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán   (Mexico)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Acute kidney injury; Aldosterone; Chronic kidney disease; Fibrosis

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

SPIRONOLACTONE;

ANIMAL; DRUG EFFECTS; ISCHEMIA; KIDNEY; MALE; PATHOPHYSIOLOGY; PROTEINURIA; RAT; REPERFUSION INJURY; VASCULARIZATION; WISTAR RAT;

ANIMALS; ISCHEMIA; KIDNEY; MALE; PROTEINURIA; RATS; RATS, WISTAR; REPERFUSION INJURY; SPIRONOLACTONE;

EID: 84933514504     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.11729     Document Type: Article

References (33)

1. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66(4):1613-1621.
2. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, MacLeod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007; 18(4):1292-1298.
3. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006; 17(4):1135-1142.
4. Wu I, Parikh CR. Screening for kidney diseases: older measures versus novel biomarkers. Clin J Am Soc Nephrol 2008; 3(6):1895-1901.
5. Jones J, Holmen J, De GJ, Jovanovich A, Thornton S, Chonchol M. Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality. Am J Kidney Dis 2012; 60(3):402-408.
6. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010.
7. Hsu CY. Yes, AKI truly leads to CKD. J Am Soc Nephrol 2012; 23(6):967-969.
8. Bucaloiu ID, Kirchner HL, Norfolk ER, Hartle JE, Perkins RM. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012; 81(5):477-485.
9. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81(5):442-448.
10. Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 2013; 84(3):457-467.
11. Leung KC, Tonelli M, James MT. Chronic kidney disease following acute kidney injury-risk and outcomes. Nat Rev Nephrol 2013; 9(2):77-85.
12. Mejia-Vilet JM, Ramirez V, Cruz C, Uribe N, Gamba G, Bobadilla NA. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 2007; 293(1):F78-F86.
13. Sanchez-Pozos K, Barrera-Chimal J, Garzon-Muvdi J, Perez-Villalva R, Rodriguez-Romo R, Cruz C, Gamba G, Bobadilla NA. Recovery from ischemic acute kidney injury by spironolactone administration. Nephrol Dial Transplant 2012; 27(8):3160-3169.
14. Ramirez V, Trujillo J, Valdes R, Uribe N, Cruz C, Gamba G, Bobadilla NA. Adrenalectomy prevents renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2009; 297(4):F932-F942.
15. Barrera-Chimal J, Perez-Villalva R, Rodriguez-Romo R, Reyna J, Uribe N, Gamba G, Bobadilla NA. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney Int 2013; 83(1):93-103.
16. Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011; 79(12):1361-1369.
17. Conger JD, Robinette JB, Hammond WS. Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 1991; 39(6):1087-1097.
18. Zager RA, Johnson AC, Andress D, Becker K. Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury. Kidney Int 2013; 84(4):703-712.
19. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16(5):535-43, 1p.
20. Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 2004; 13(1):1-7.
21. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281(5):F887-F899.
22. Horbelt M, Lee SY, Mang HE, Knipe NL, Sado Y, Kribben A, Sutton TA. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol 2007; 293(3):F688-F695.
23. Zager RA, Johnson AC, Becker K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease. Am J Physiol Renal Physiol 2011; 301(6):F1334-F1345.
24. Grgic I, Campanholle G, Bijol V, Wang C, Sabbisetti VS, Ichimura T, Humphreys BD, Bonventre JV. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 2012; 82(2):172-183.
25. Henry RJ, Sobel C, Segalove M. Turbidimetric Determination of Proteins with Sulfosalicylic and Trichloracetic Acids. Proceedings of the Society for Experimental Biology and Medicine 1956; 92(4):748-751.
26. Stroo I, Stokman G, Teske GJ, Raven A, Butter LM, Florquin S, Leemans JC. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol 2010; 22(6):433-442.
27. Bechtel W, McGoohan S, Zeisberg EM, Muller GA, Kalbacher H, Salant DJ, Muller CA, Kalluri R, Zeisberg M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16(5):544-550.
28. Basile DP, Leonard EC, Beal AG, Schleuter D, Friedrich JL. Persistent oxidative stress following renal ischemia reperfusion injury increases Ang II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol 2012.
29. Basile DP, Friedrich JL, Spahic J, Knipe N, Mang H, Leonard EC, Changizi-Ashtiyani S, Bacallao RL, Molitoris BA, Sutton TA. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 2011; 300(3):F721-F733.
30. Linder A, Fjell C, Levin A, Walley KR, Russell JA, Boyd JH. Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med 2014; 189(9):1075-1081.
31. Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 2012; 82(5):516-524.
32. Kramann R, Tanaka M, Humphreys BD. Fluorescence Microangiography for Quantitative Assessment of Peritubular Capillary Changes after AKI in Mice. J Am Soc Nephrol 2014.
33. Schnaper HW, Jandeska S, Runyan CE, Hubchak SC, Basu RK, Curley JF, Smith RD, Hayashida T. TGF-beta signal transduction in chronic kidney disease. Front Biosci 2009; 14:2448-2465.